Tag Archives: Lupus

Drug shows promise in reversing kidney damage caused by lupus

By Bill Hathaway A drug used for cancer therapy has shown promise in reversing kidney damage caused by systemic lupus erythematosus (SLE, or lupus), according to a Yale-led study published April 8 in the journal Science Translational Medicine. “Kidney damage affects about half of the patients with lupus, sometimes leading to renal failure with a requirement… Read More »

GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above

Print this page London UK, Philadelphia USA April 26, 2019 — GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review, the use of the intravenous (IV) formulation of Benlysta (belimumab), a B-lymphocyte stimulator (BLyS)-specific inhibitor, in children with lupus from as young as five years of age. Dr… Read More »